We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Product Name:
Artemisia Dracunculus Extract
Specification:
4:1
Appearance:
Yelllow brown powder
CAS No.:
63968-64-9
Package:
25kg/drum
Products Description:
Functions:
Anti-malaria, Artemisinin has also proven itself as a safe and effective treatment for malaria in over two million patients. Anti-cancer Now studies are also showing that Artemisinin is effective against a wide variety of cancers as shown in a series of successful experiments. The most effective is leukemia and colon cancer. Intermediate activities were also shown against melanoma, breast, ovarian, prostate, CNS and renal cancer.
Application:
1. Restrain plasmodium growth and directly kill plasmodium.
2. Anti-inflammatory and canker.
3. Relieve cough and asthma.
4. Reduce blood pressure, allay a fever and restrain a dermatophyte.
According to over 2000 clinical case studies, when used for the treatment of tertian fever, it is better than chloroquine in terms of time to suppress the pathogen. No adverse effect in clinical cases. Esp. Useful for the treatment of cases resistant to chloroquine. However, the short term recurrance rate is higher than chloroquine.
One year of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
